Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Shi, Jing" or (type any "bookEditor issueEditor" and editor="Shi, Jing")

Add to list
- PhD Thesis
- open access
Zhang Taiyan’s early interpretation of the Zuo Zhuan

Jing Shi (UGent)

(2020)
Add to list
- Journal Article
- A1
- open access
Kinetics of urinary cell cycle arrest markers for acute kidney injury following exposure to potential renal insults

Marlies Ostermann, Peter A McCullough, Lui G Forni, Sean M Bagshaw, Michael Joannidis, Jing Shi, Kianoush Kashani, Patrick M Honore, Lakhmir S Chawla, John A Kellum, et al.

(2018) CRITICAL CARE MEDICINE. 46(3). p.375-383
Add to list
Tissue inhibitor metalloproteinase-2 (TIMP-2)∙IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI

Jay L Koyner, Andrew D Shaw, Lakhmir S Chawla, Eric Hoste (UGent) , Azra Bihorac, Kianoush Kashani, Michael Haase, Jing Shi and John A Kellum

(2015) JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 26(7). p.1747-1754
Add to list
Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

Eric Hoste (UGent) , Peter A McCullough, Kianoush Kashani, Lakhmir S Chawla, Michael Joannidis, Andrew D Shaw, Thorsten Feldkamp, Denise L Uettwiller-Geiger, Paul McCarthy, Jing Shi, et al.

(2014) NEPHROLOGY DIALYSIS TRANSPLANTATION. 29(11). p.2054-2061
Add to list
- Journal Article
- A1
- open access
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury

Kianoush Kashani, Ali Al-Khafaji, Thomas Ardiles, Antonio Artigas, Sean M Bagshaw, Max Bell, Azra Bihorac, Robert Birkhahn, Cynthia M Cely, Lakhmir S Chawla, et al.

(2013) CRITICAL CARE. 17(1).

Academic Bibliography

Zhang Taiyan’s early interpretation of the Zuo Zhuan

Kinetics of urinary cell cycle arrest markers for acute kidney injury following exposure to potential renal insults

Tissue inhibitor metalloproteinase-2 (TIMP-2)∙IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury

Contents

Support

Contact